Hoiland RL, Smith KJ, Carter HH, Lewis NC, Tymko MM, Wildfong KW, Bain AR, Green DJ, Ainslie PN. Shear-mediated dilation of the internal carotid artery occurs independent of hypercapnia. dence for shear stress as a regulator of carotid artery dilation in response to increased arterial CO2 was recently demonstrated in humans during sustained elevations in CO2 (hypercapnia); however, the relative contributions of CO2 and shear stress to this response remains unclear. We examined the hypothesis that, after a 30-s transient increase in arterial CO2 tension and consequent increase in internal carotid artery shear stress, internal carotid artery diameter would increase, indicating shear-mediated dilation, in the absence of concurrent hypercapnia. In 27 healthy participants, partial pressures of end-tidal O2 and CO2, ventilation (pneumotachography), blood pressure (finger photoplethysmography), heart rate (electrocardiogram), internal carotid artery flow, diameter, and shear stress (high-resolution duplex ultrasound), and middle cerebral artery blood velocity (transcranial Doppler) were measured during 4-min steady-state and transient 30-s hypercapnic tests (both ϩ9 mmHg CO2). Internal carotid artery dilation was lower in the transient compared with steady-state hypercapnia (3.3 Ϯ 1.9 vs. 5.3 Ϯ 2.9%, respectively, P Ͻ 0.03). Increases in internal carotid artery shear stress preceded increases in diameter in both transient (time: 16.8 Ϯ 13.2 vs. 59.4 Ϯ 60.3 s, P Ͻ 0.01) and steady-state (time: 18.2 Ϯ 14.2 vs. 110.3 Ϯ 79.6 s, P Ͻ 0.01) tests. Internal carotid artery dilation was positively correlated with shear rate area under the curve in the transient (r 2 ϭ 0.44, P Ͻ 0.01) but not steady-state (r 2 ϭ 0.02, P ϭ 0.53) trial. Collectively, these results suggest that hypercapnia induces shear-mediated dilation of the internal carotid artery in humans. This study further promotes the application and development of hypercapnia as a clinical strategy for the assessment of cerebrovascular vasodilatory function and health in humans.
NEW & NOTEWORTHY Shear stress dilates the internal carotid artery in humans. This vasodilatory response occurs independent of other physiological factors, as demonstrated by our transient CO2 test, and is strongly correlated to shear area under the curve. Assessing carotid shear-mediated dilation may provide a future avenue for assessing cerebrovascular health and the risk of cerebrovascular events.
cerebral blood flow; carbon dioxide; shear stress; flow-mediated dilation; transcranial Doppler; ultrasound THE ENDOTHELIUM is integral to the maintenance of vascular health and function in humans. Endothelial dysfunction is an early and integral event in the pathogenesis of atherosclerosis as well as cardio-and cerebrovascular diseases (20) . In the peripheral and coronary vasculature, flow-mediated dilation (FMD) has been used as a functional bioassay to assess endothelial health. The FMD test strongly predicts cardiac events (18) , potentially allowing for preclinical detection of future cardiovascular disease (12) . While the conventional FMD test is based on the notion that a healthy endothelium produces autocoids [e.g., nitric oxide (NO)] that induce a quantifiable dilator response to an imposed increase in shear stress (17) , there is currently no equivalent assessment of cerebrovascular function in humans. Although standard CO 2 reactivity tests using transcranial Doppler are predictive of cerebrovascular events (i.e., stroke) in individuals with preexisting carotid stenosis (19) , its use is limited, since it does not provide significant predictive value pertaining to stroke risk in apparently healthy individuals (30) . Other metrics of cerebrovascular function, such as neurovascular coupling (27) and cerebral autoregulation (39, 44) , are similarly impaired in clinical populations but are not predictive of risk in apparently healthy individuals. Therefore, the development of an FMDtype test that could potentially provide an index of cerebrovascular endothelial function may prove to be clinically impactful.
Recently, our group has provided the first evidence in humans of shear-mediated dilation in the internal carotid artery (ICA) (10) . Here, we demonstrated that vascular responsiveness to CO 2 was related to the rise in intra-arterial shear stress, leading to vasodilation with a similar time dependency to that of peripheral FMD. However, the carotid vasodilation observed in that study coincided with elevated arterial PCO 2 (Pa CO 2 ) levels, and we could not partition the effects of shear stress from those occurring secondary to sustained hypercapnia [e.g., elevated blood pressure (33) , cardiac output (7), chemo-receptor-mediated sympathoactivation (28) , and potential direct vasomotor effects of CO 2 (21, 23, 47) ]. As a result, the contribution of shear-dependent mechanisms to human cerebral blood flow (CBF) regulation and carotid dilator function requires further investigation in vivo. Therefore, the primary purpose of this experiment was to extend our previous findings (10) , using a test without sustained hypercapnia, to quantify the role that shear stressdependent mechanisms play in carotid dilation in response to CO 2 reactivity. It was hypothesized that transient (30-s) increases in end-tidal PCO 2 (PET CO 2 ) would produce an ICA shear response similar to that of a peripheral FMD test (i.e., bell curve). We further reasoned that, upon return of PET CO 2 to baseline values and consequent withdrawal of the direct effects of CO 2 , a time-dependent dilation of the ICA would occur (e.g., 30-to 60-s delay from the shear onset), implying a shear-specific mechanism that is consistent with that observed in peripheral vessels of young healthy individuals (9) .
MATERIALS AND METHODS

Ethical Approval
This study was approved by the University of British Columbia Clinical Research Ethics Board and the University of Western Australia Human Research Ethics Committee, and data were subsequently collected at both institutions. Before participation in the study, all participants completed written informed consent. All procedures conformed with standards set by the Declaration of Helsinki.
Research Participants
Twenty-seven healthy (22 men and 5 women) young volunteers (means Ϯ SD, 22 Ϯ 3 yr, body mass index: 22 Ϯ 2 kg/m 2 ) were recruited to participate in this study. After written informed consent and familiarization, participants attended the laboratory on one occasion having fasted for Ն2 h and refrained from exercise, alcohol, and caffeine for 24 h. During familiarization, participants were screened to ensure that reliable ICA ultrasound images and middle cerebral artery (MCA) signals could be obtained. Participants were familiarized with the remaining experimental equipment and procedures during this session. All participants were free of cardiovascular, respiratory, and cerebrovascular disease, were nondiabetic, and were not taking any prescription drugs (other than oral contraceptives, n ϭ 4) at their time of participation, as determined by a screening questionnaire. All women were tested in days 1-3 of their follicular phase. Of the 27 participants recruited, 24 participants completed both CO 2 protocols while 3 participants only completed the transient CO2 protocol.
Experimental Measures
Cardiorespiratory measures. All cardiorespiratory variables were sampled continuously at 1 kHz via an analog-to-digital converter (Powerlab 16/30, AD Instruments, Colorado Springs, CO). Heart rate (HR) was measured by a three-lead electrocardiogram (ADI bioamp ML132), whereas beat-to-beat blood pressure was measured by finger photoplethysmography (Finometer PRO, Finapres Medical Systems, Amsterdam, The Netherlands). The Finometer reconstructed brachial waveform was used for the calculation of mean arterial pressure (MAP) after values were back calibrated to the average of three automated brachial blood pressure measurements made over 5 min at rest (Tangoϩ, SunTech, Morrisville, NC). Both PET CO 2 and end-tidal PO 2 (PET O 2 ) were sampled at the mouth and recorded by a calibrated gas analyzer (model ML206, AD Instruments) while respiratory flow was measured by a pneumotachograph (model HR 800L, HansRudolph, Shawnee, KS) connected in series to a bacteriological filter. All data were interfaced with LabChart (version 7).
Dynamic end-tidal forcing. PET O 2 and PET CO 2 were controlled by a portable dynamic end-tidal forcing system that has been previously described in detail (42, 43) . Our end-tidal forcing system effectively controls end-tidal gases through wide ranges of PET CO 2 and PET O 2 independent of ventilation (42, 43) and has been previously used for similar PET CO 2 manipulations (21) .
Cerebrovascular measures. Blood velocity in the right MCA (MCAv) was measured using 2-MHz transcranial Doppler ultrasound (TCD, Spencer Technologies, Seattle, WA). The TCD probe was fixed to a headpiece (model M600 bilateral head frame, Spencer Technologies) and secured in place. The MCA was insonated through the middle transtemporal window using previously described location and standardization techniques (46) . ICA measurements. Right ICA blood velocity (ICAv) and vessel diameter were measured using a 10-MHz multifrequency linear array duplex ultrasound (Terason T3200, Teratech, Burlington, MA). Specifically, B-mode imaging was used to measure arterial diameter while pulse-wave mode was used to concurrently measure peak blood velocity. The diameter and velocity of the ICA were measured at least 1.5 cm distal to the common carotid bifurcation to eliminate recordings of turbulent and retrograde flow and nonuniform shear. Great care was taken to ensure that the insonation angle (60°) was unchanged throughout each test. Furthermore, upon acquisition of the first ultrasound image (i.e., resting baseline), there was no alteration of B-mode gain to avoid any artificial changes in arterial wall brightness/ thickness. All recordings were made in accordance with published guidelines (41) .
All recordings were screen captured and stored as video files for offline analysis. This analysis involved concurrent determination of arterial diameter and peak blood velocity at 30 Hz using customized edge detection and wall tracking software (BloodFlow Analysis, version 5.1) designed to mitigate observer bias (49) . Our within-day coefficient of variation for the assessment of ICA diameter is 1.5% using this technique (21) . Blood flow and shear rate were subsequently calculated as previously described (9, 21) .
Experimental Protocol
Carotid shear-mediated dilation tests. Before the study began, pilot testing was ran to determine the optimal PET CO 2 change required to elicit a maximal transient shear stress response. Although it is well established that the CBF response is linear with elevations in PET CO 2 (1), we determined that there was no appreciable difference in the transient test shear response between a targeted PET CO 2 stimuli of ϩ9 or ϩ15 mmHg. Given that ϩ15 mmHg leads to a greater extent of participant discomfort and a larger ventilatory response, which would increase the difficulty of acquiring ultrasound recordings of the ICA, we reasoned that a ϩ9-mmHg stimulus would be better suited to address our research question. In addition, the ϩ9-mmHg stimulus is roughly comparable to what would be induced by a fraction of inspired CO 2 of 0.05; this level is commonly used in other studies (1) .
Two separate CO2 tests were used to assess the influence of shear and flow on ICA vascular tone: 1) a transient CO2 test (ϩ9-mmHg PET CO 2 ) to simulate the shear dynamics characteristic of a postocclusion brachial cuff release in standardized peripheral FMD tests (Figs. 1 and 2) (40) and 2) a steady-state CO 2 test to determine maximal reactivity/ dilation to the same ϩ9-mmHg stimulus. The steady-state CO2 test was conducted 15 min after the transient test.
THE TRANSIENT CO2 TEST. Participants lay supine while breathing room air. After 5 min of resting data collection, participants breathed simulated room air delivered from the end-tidal forcing system (i.e., PET O 2 and PET CO 2 did not change) for 2 min. Participants were then paced at 20 breaths/min through verbal coaching and visual feedback while end-tidal values were maintained (i.e., did not change) for an additional 2 min. Breathing was maintained at 20 breaths/min for the remainder of the trial. This approach was used to improve the ability of the end-tidal forcing systems to abruptly manipulate PET CO 2 in a controlled fashion, since a higher breathing rate allows for quicker gas manipulations. Furthermore, this eliminated the potential for abrupt changes in minute ventilation (V E) due to CO2 chemosensitivity, which could interfere with ultrasound imaging (e.g., large neck muscle movements) and act as a confounding physiological factor. At the 2-min mark, PET CO 2 was abruptly (~5 s) elevated to ϩ9 mmHg above baseline for 30 s and then quickly returned to baseline values, which were maintained for 3 additional minutes. Reported data are from the last minute of baseline hyperventilation onward.
THE STEADY-STATE CO2 TEST. Participants lay supine while breathing room air. After 5 min of resting data collection, the participant breathed simulated room air on the end-tidal forcing system. After 2 min of steady breathing, PET CO 2 was abruptly (~5 s) elevated to ϩ9 mmHg above baseline and maintained for 4 min. After 4 min, participants returned to room air breathing.
Data Analysis
Data extraction and carotid shear-mediated dilation software. All data from LabChart (e.g., MCAv, MAP, PET CO 2 , and PET O 2 ) were down sampled to 50 Hz and exported into Microsoft Excel. Vascular data were interpolated at 50 Hz, exported into the same Excel spreadsheet, and time aligned with the LabChart data. The Excel spreadsheet was reopened as a LabChart data file, and all cardiovascular/cerebrovas- CO 2 ) . The increase in CO2 produced an increase in cerebral blood flow (CBF) and therefore cerebral shear rate (gray circles) that mirrored that subsequent to brachial cuff release during a peripheral flow-mediated dilation (FMD) test (see Fig. 2 cular data were exported to a new Excel spreadsheet in beat-by-beat averages, whereas all respiratory variables were exported on a breathby-breath basis. These variables were subsequently analyzed using custom-designed shear-mediated dilation software (Labview) as previously explained in detail (10) . In brief, the data were filtered, and the following variables were automatically detected and calculated: 1) baseline values; 2) peak responses, and; 3) relative changes (in %). In addition, a threshold selection algorithm was applied to each data array (e.g., ICA shear and ICA diameter), which identified threshold points for the increase in each variable after the onset of CO2 administration. Once the software had automatically detected the threshold points, they were depicted on the filtered and raw data array and visually inspected to ensure they met the following criteria: 1) the algorithm-detected threshold point occurred before the peak value and 2) the variable did not decrease below the algorithm-detected threshold point before the peak value occurring. Of the 240 responses analyzed, 151 responses met the agreed criteria, and their automatically detected points were accepted. In the remaining 89 cases (37%), the threshold points were manually adjusted by two independent investigators to a point where each deemed there was a clear deviation from baseline that met the above criteria. The mean of these manually assessed points was entered in the analysis. The coefficient of variation for the analysis of the threshold points detected using the above systematic approach was 4.2% overall and 11.2% between the 89 manually adjusted files. The shear rate area under the curve (AUC) was also calculated for both the transient and steady-state trials, in accordance with the analytic methods used for brachial FMD (9, 40) (i.e., from the onset of CO2 stimulus until peak dilation occurred). Data exclusion criteria. Of the subjects tested, four trials were excluded from analysis of the steady-state CO2 tests while seven trials were excluded from the transient CO2 tests. Additionally, there were three subjects who only completed the transient CO2 test (not both trials). Thus, the resulting sample sizes were n ϭ 20 for both the steady-state CO2 and transient CO2 tests, with 13 subjects having repeated measures across both trials. Ultrasound videos were visually inspected before analyses and were excluded based on the following criteria: 1) the occurrence of an overt angle change (n ϭ 2), 2) excessive movement of the vessel [e.g., due to high ventilation (n ϭ 3)], and 3) overall poor image quality [e.g., blurry vessel walls (n ϭ 4)]. In two cases, a test was excluded after video analysis because of low-fidelity wall tracking despite the visual appearance of a clear vessel wall. Therefore, sample size is noted throughout the text for all statistical comparisons.
Statistical Analyses
No statistical differences were found between male and female vascular responses in the present study; therefore, data were pooled for analyses. Sample sizes were based off of previous research by our group investigating vasomotion of the ICA (10, 21, 47) . Comparisons between baseline and peak values within trial were made using two-tailed paired t-tests. Because of the differing participants for each trial (see Data exclusion criteria), betweentrial comparisons were made using a linear mixed-model analysis with a compound symmetry covariance structure (fixed factor: steady-state vs. transient test) to account for this drop out. Pearson correlations were used to assess the relationship between vasodilatory responses during the transient and steady-state CO 2 protocols in the subjects with repeated measures (n ϭ 13) and to determine the relationship between shear AUC and dilation in each trial (transient: n ϭ 19 and steady state: n ϭ 20). For the shear AUC and dilation bivariate analysis, a statistical outlier was determined using bagplot analysis (34) . All statistical analyses were performed using SPSS (IBM statistics, version 22.0).
RESULTS
Carotid Shear-Mediated Dilation
From the onset of elevated PET CO 2 (Fig. 3) , the delay for ICA shear to increase was 16 (Fig. 3) .
During the transient and steady-state hypercapnic tests, the ICA dilated by 3.3 Ϯ 1.9% (n ϭ 20, P Ͻ 0.01) and 5.3 Ϯ 2.9% (n ϭ 20, P Ͻ 0.01), respectively. The steady-state elevation in PET CO 2 produced the greatest dilation, as reflected in a 60% greater increase (P ϭ 0.03; Fig. 4 ). Shear rate increased from 330.0 Ϯ 74.2 s Ϫ1 to a peak value of 448.5 Ϯ 111.7 s Ϫ1 (n ϭ 20, P Ͻ 0.01) in the transient CO 2 trial and from 337.3 Ϯ 56.6 to 526.8 Ϯ 83.5 s Ϫ1 (n ϭ 20, P Ͻ 0.01) in the steady-state trial. The increase in shear rate during the steady-state trial was greater than during the transient test (189.5 Ϯ 49.9 vs. 118.5 Ϯ 53.8 s Ϫ1 , P Ͻ 0.01). Shear rate AUC for the transient trial was 43,053 Ϯ 21,277 s Ϫ1 (n ϭ 19) and 131,476 Ϯ 30,880 s Ϫ1 (n ϭ 20) in the steady-state trial (P Ͻ 0.01 by independentsamples t-test). Shear rate AUC was correlated to the magnitude of vasodilation in the transient test (n ϭ 19, r 2 ϭ 0.44, P Ͻ 0.01); however, this relationship was not present in the steady-state trial (r 2 ϭ 0.02, P ϭ 0.53; Fig. 5 ). 
Intra-Versus Extracranial Cerebral Hemodynamics
Blood Pressure Regulation
During the transient CO 2 test, MAP increased from 94.6 Ϯ 12.5 mmHg to a peak value of 104.2 Ϯ 13.6 mmHg (P Ͻ 0.01), whereas the time of occurrence for peak MAP (81.2 Ϯ 73.1 s) was not statistically different from the time of peak dilation (110.1 Ϯ 69.1 s, P ϭ 0.20). However, the time to peak MAP and dilation were not related within subject (r 2 ϭ 0.14, P ϭ 0.06), nor was the magnitude of dilation and change in MAP (r 2 ϭ 0.09, P ϭ 0.22). During the steady-state hypercapnia, MAP increased from 94.2 Ϯ 10.4 mmHg to a peak value of 105.8 Ϯ 11.3 mmHg (P Ͻ 0.01), whereas the time of occurrence for peak MAP (169.0 Ϯ 96.3 s) was earlier than that for peak dilation (283.6 Ϯ 56.1 s, P Ͻ 0.01). There was no relationship in the time to peak dilation and peak MAP (r 2 ϭ 0.002, P ϭ 0.43).
DISCUSSION
The present study outlines a novel experimental design aimed at 1) assessing shear-mediated dilation of cerebral conduit arteries without the confounding influence of sustained increases in Pa CO 2 and 2) reinforcing the existence of shearmediated dilation of the ICA (10, 21) . We observed dilation of the ICA in response to both transient and steady-state hyper-capnia. Under both conditions, increases in shear stress preceded dilation of the ICA in a time-dependent manner. Vasodilation of the ICA in the transient trial was strongly correlated to the increase in shear AUC, implicating shear as the primary stimulus for dilation, consistent with observations in brachial, femoral, and coronary arteries (32) .
The assessment of FMD in peripheral arteries dates back Ͼ20 yr to the landmark study by Celermajer et al. (12) . This technique evolved into a method for assessing the function and health of endothelial cells in the general circulation (17) . However, to date, there is no equivalent method of assessing cerebral conduit artery shear-mediated regulation. In humans, the ICA conveys blood flow to the brain, and bilaterally this accounts for~70% of global CBF (50) . In addition to serving as cerebral conduit vessels, the ICAs regulate CBF (48) and provide the most accessible avenue (41) to assess cerebral endothelial function using duplex ultrasound. Therefore, the measurement of ICA diameter during a controlled and transient elevation in shear stress may provide a valid paradigm and for the specific assessment of cerebral conduit artery endothelial function (or dysfunction) (40) . Although ischemia-induced hyperemia is used in peripheral FMD tests, this is obviously not possible in the cerebral vasculature (37) . However, the present study indicates that hypercapnia-induced vasodilation, in particular using transient exposure, induces ICA dilation after increases in intravascular shear stress of a similar manner and profile to postocclusion cuff release (10) . Given the congruent shear dynamics of a peripheral FMD test and the current carotid FMD test, in addition to the strong relationship between shear AUC and vasodilation, it appears that transient elevations in CO 2 provide a robust (and relatively specific) method to perturb shear-mediated regulation of CBF. We therefore propose a novel technique to assess "cerebrovascular FMD" in the present study; however, pharmacological inhibition of endothelial NO synthase is necessary to confirm the potential applicability of this technique. The lack of correlation between shear AUC and dilation in the steady-state trial indicates that sustained hypercapnia is likely not an adequate method to assess shear-mediated regulation of the ICA due to a larger influence of confounding factors (increased blood pressure, etc.).
Our data implicate shear-dependent mechanisms as key contributors to vasodilation in the ICA during a CO 2 reactivity test (Figs. 4 and 5) in accordance with previous study (10) . Considering the transient CO 2 test elicited a more rapid, albeit lower, ICA dilation compared with the steady-state test, our findings suggest that ICA dilation in the transient test is less influenced by extraneous factors (e.g., blood pressure, sympathetic nervous activity, metabolism, direct effects of CO 2 /pH, etc.) As shown in Fig. 5 , the relationship between shear AUC and dilation occurs within a range between 0 and 100,000 s Ϫ1 , but in the steady-state trial where shear AUC is Ͼ100,000 s Ϫ1 , this relationship is lost. This may be due to two potential factors: 1) a ceiling effect of shear on ICA vasodilation and 2) that, as previously mentioned, sustained CO 2 engages other confounding physiological responses (e.g., elevated blood pressure) that obscure the relationship between shear AUC and vasodilation. Therefore, it appears the transient trial more closely resembles the NO-mediated FMD observed in the peripheral vasculature (17, 40) , which is further supported by observations that other endothelium-derived relaxing factors [e.g., prostaglandins (21)] do not possess an obligatory role in hypercapnic cerebral vasodilation. That the percent dilation was only modestly correlated within subjects between the transient and steady-state CO 2 tests indicates that distinct mechanisms may be evoked differentially in response to varying stimuli (i.e., time of hypercapnia). This is consistent with findings from the peripheral FMD test, where 5 min of ischemia induces a largely NO-mediated dilation, whereas longer periods of ischemia induce compensatory redundant mechanisms resulting in less NO dependency (24) . However, it must be stressed that studies pharmacologically inhibiting endothelial NO synthase activity have not consistently demonstrated a role for NO in hypercapnic vasodilation (22, 35, 45) . These variable findings may be related to the use of velocity indexes of CBF (i.e., TCD; as discussed in Ref. 2) , which are unable to detect and quantify changes in vessel diameter. In addition, systemic administration of NO blockers such as N G -monomethyl-L-arginine has both direct and indirect reflex effects on vasomotor tone, and these are countervailing, making the impacts of such drugs difficult to interpret.
A delayed response (~60 s) to reach maximal steady-state CBF for a given step change in PET CO 2 has been demonstrated previously (10, 36) . Furthermore, steady-state hypercapnia is reported to elicit higher cerebrovascular reactivity than nonsteady-state tests [e.g., rebreathing (25) ]. This disparity in reactivity may be explained by the time-dependent nature of endothelial NO synthase upregulation and consequent NOmediated vasodilation, which may not be fully engaged at the termination of a progressive and dynamic stimulus. By quantifying the maximal dilation to a steady-state CO 2 stimulus in addition to the vasomotor reaction to a transient elevation in CO 2 and shear, we have provided insights into the percent contribution of shear-dependent mechanisms to total CO 2 reactivity. Furthermore, this highlights that~40% of CO 2 reactivity is not explained by shear and may be partially attributable to changes in MAP (3, 26, 31) , increases in cardiac output, and/or direct effects of Pa CO 2 /pH. The difference in time to peak dilation during the transient and steady-state CO 2 test likely indicates a different time course of these mechanism(s) on vasomotor tone. Therefore, while shear mechanisms likely acted in the same time course between tests, it is the additional stimuli that results in a further and delayed maximal dilation during steady-state elevations in CO 2 .
When considering the contribution of shear-dependent mechanisms to cerebrovascular dilation, one must also consider the potential for myogenic influences during hypercapniamediated increases in MAP (14) . Increases in cerebral perfusion pressure have been shown to produce cerebral vasoconstriction (15) ; therefore, myogenic constriction may have masked vasodilation to some degree (resulting in underestimation of shear-mediated vasodilation) and/or be related to the variable contribution of shear-dependent mechanisms to hypercapnia-mediated vasodilation. The opposing forces of shear-mediated dilation and myogenic constriction have been previously demonstrated in peripheral vessels (4, 29) .
Methodological Considerations
Recently, it has become convention to normalize peripheral FMD tests via logarithmic transformation of baseline diameter, peak diameter, and shear rate AUC to allometrically scale for artery size and account for between-subject variations in the shear stimulus (5, 6) . The purpose of these corrections is to better estimate the endothelial responsiveness to a shear stimulus. Here, we have not scaled for baseline diameter and shear AUC between trials, since the purpose of the present study was not to evoke and subsequently quantify a change in endothelial function but to determine the experimental feasibility of a transient increase in ICA shear (via elevated PET CO 2 ) in eliciting a measureable change in arterial diameter. Indeed, endothelial function should not be different between the two trials given no intervention was present.
Although we have used dynamic end-tidal forcing to control PET CO 2 , determining the efficacy of the Douglas bag technique for a 30-s manipulation of CO 2 may provide great utility given the reduced technical demand and consequently easier transition into a clinical setting. Further determining the within-and between-day variation in transient CO 2 -mediated ICA vasodilation will help determine its potential translation in a clinical setting.
Perspectives
Turbulent flow and nonuniform shear stress, which are characteristic of the carotid bulb and ICA, render the carotid vasculature a "high-risk" area for atherogenesis, wall thickening, and consequent vascular dysfunction (8, 16, 38) . Therefore, the present carotid FMD test may possess future potential to detect early carotid and cerebral vascular dysfunction, before the development of overt wall thickening or intractable plaque deposition. Analogous to the peripheral FMD approaches, which predict future cardiovascular events (18) , our carotid test may provide a useful clinical window into subclin-H29 INTERNAL CAROTID SHEAR-MEDIATED DILATION ical atherogenesis and also enable treat-to-target assessment of management efficacy. While steady-state CO 2 reactivity tests have shown a strong ability to predict cerebral vascular events in clinical populations [e.g., carotid stenosis (19) ], they have yet to demonstrate predictive value relative to cerebral vascular risk in healthy individuals (30) . The inability to specifically predict cerebral vascular risk may be related to several factors, including 1) previous use of velocity indexes of CBF and consequent inability to directly quantify vasomotion (2, 13) and 2) the confounding nature of the myriad physiological consequences secondary to sustained hypercapnia [i.e., elevated blood pressure (33) and cardiac output (7), chemoreceptor-mediated sympathoactivation (28) , and the potential for direct vasodilatory effects of CO 2 /pH (21, 23, 47) ]. Our approach mitigates these limitations by directly visualizing arterial diameter change and quantifying the magnitude and profile of the shear stimulus. It is tailored to perturb cerebrovascular endothelial function with reduced input from confounding physiological factors and couples concurrent measurement of cerebral conduit artery diameter, flow, and shear at high temporal and spatial resolution. Future research should aim to 1) determine the influence of transiently elevated shear on ICA vasodilation before and after NO blockade to confirm endothelial involvement and 2) determine the magnitude by which carotid shear-mediated dilation may be reflective of cerebral vascular health and risk of cerebrovascular events. 
